Translational andrology and urology
Efficacy at a cost?-quality of life implications of PARP inhibition in the homologus recombination repair (HRR) cohort of TALAPRO-2.
Jorge Esteban-Villarrubia, Elena Castro
Published: 202510.21037/tau-2025-645
No abstract available for this study.